E.U. Steinhauer

1.4k total citations · 1 hit paper
10 papers, 982 citations indexed

About

E.U. Steinhauer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, E.U. Steinhauer has authored 10 papers receiving a total of 982 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in E.U. Steinhauer's work include Bone health and treatments (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). E.U. Steinhauer is often cited by papers focused on Bone health and treatments (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). E.U. Steinhauer collaborates with scholars based in Germany, Austria and Switzerland. E.U. Steinhauer's co-authors include Christophe Borg, Alberto Sobrero, O. Kisker, Heinz‐Josef Lenz, Howard A. Burris, Cathy Eng, Werner Scheithauer, Joan Maurel, Justin Kopit and Gary Middleton and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

E.U. Steinhauer

10 papers receiving 950 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer

2008 726 citations Alberto Sobrero, Joan Maurel et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E.U. Steinhauer Germany	6	860	370	196	145	131	10	982
Rosella Spadi Italy	13	1.1k 1.3×	489 1.3×	324 1.7×	193 1.3×	358 2.7×	28	1.4k
Gaston Demonty Switzerland	15	458 0.5×	170 0.5×	73 0.4×	251 1.7×	197 1.5×	41	715
José María Viéitez Spain	14	1.1k 1.3×	563 1.5×	290 1.5×	195 1.3×	132 1.0×	52	1.4k
Yada Kanjanapan Australia	12	583 0.7×	273 0.7×	32 0.2×	58 0.4×	87 0.7×	31	802
Patrizia Racca Italy	19	472 0.5×	374 1.0×	81 0.4×	39 0.3×	436 3.3×	40	885
В. С. Медведев Russia	4	397 0.5×	242 0.7×	66 0.3×	99 0.7×	97 0.7×	11	950
Leonardo Gomes da Fonseca Brazil	15	318 0.4×	176 0.5×	350 1.8×	126 0.9×	132 1.0×	68	804
Joe McKendrick Australia	7	865 1.0×	420 1.1×	292 1.5×	176 1.2×	170 1.3×	9	1.1k
Yu-Hong Li China	15	606 0.7×	392 1.1×	68 0.3×	101 0.7×	285 2.2×	19	922
Y. Hei United States	9	634 0.7×	335 0.9×	20 0.1×	29 0.2×	118 0.9×	20	800

Countries citing papers authored by E.U. Steinhauer

Since Specialization

Citations

This map shows the geographic impact of E.U. Steinhauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.U. Steinhauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.U. Steinhauer more than expected).

Fields of papers citing papers by E.U. Steinhauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.U. Steinhauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.U. Steinhauer. The network helps show where E.U. Steinhauer may publish in the future.

Co-authorship network of co-authors of E.U. Steinhauer

This figure shows the co-authorship network connecting the top 25 collaborators of E.U. Steinhauer. A scholar is included among the top collaborators of E.U. Steinhauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.U. Steinhauer. E.U. Steinhauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Huber, Rudolf M., David F. Heigener, Cornelius F. Waller, et al.. (2012). Topotecan/Cisplatin Compared with Cisplatin/Etoposide as First-Line Treatment for Patients with Extensive Disease Small-Cell Lung Cancer: Final Results of a Randomized Phase III Trial. Journal of Thoracic Oncology. 7(9). 1432–1439. 39 indexed citations

Sobrero, Alberto, Joan Maurel, Louis Fehrenbacher, et al.. (2008). EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer. Journal of Clinical Oncology. 26(14). 2311–2319. 726 indexed citations breakdown →

Pecherstorfer, Martin, et al.. (2003). Efficacy and safety of ibandronate in the treatment of hypercalcemia of malignancy: a randomized multicentric comparison to pamidronate. Supportive Care in Cancer. 11(8). 539–547. 49 indexed citations

Rizzoli, R., D. Thiébaud, Nigel Bundred, et al.. (1999). Serum Parathyroid Hormone-Related Protein Levels and Response to Bisphosphonate Treatment in Hypercalcemia of Malignancy. The Journal of Clinical Endocrinology & Metabolism. 84(10). 3545–3550. 32 indexed citations

Pecherstorfer, Martin, Z. Herrmann, Jean‐Jacques Body, et al.. (1996). Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy.. Journal of Clinical Oncology. 14(1). 268–276. 98 indexed citations

Rizzoli, R., D. Thiébaud, N.J. Bundred, et al.. (1995). Pathophysiology of malignant hypercalcemia in relation with serum parathyroid hormone-related protein levels and response to the bisphosphonate ibandronate. Bone. 17(6). 616–616. 2 indexed citations

Köppler, H., Karl-Heinz Pflüger, R. Pfab, et al.. (1991). Sequential versus alternating chemotherapy for high grade non‐hodgkin's lymphomas: A randomized multicentre trial. Hematological Oncology. 9(4-5). 217–223. 5 indexed citations

Köppler, H., Karl-Heinz Pflüger, R. Pfab, et al.. (1991). CHOEP versus Alternating hCHOP/IVEP for High Grade Non-Hodgkin’s Lymphomas: A Randomized Multicentre Trial. Oncology Research and Treatment. 14(2). 181–184. 1 indexed citations

Köppler, H., Karl-Heinz Pflüger, R. Pfab, et al.. (1990). Sequential versus Alternating Chemotherapy for High-Grade Non-Hodgkin’s Lymphomas: Preliminary Results of a Phase III Multicentre Trial. Oncology Research and Treatment. 13(1). 28–32. 1 indexed citations

10.

Zeff, R A, Jacob Gopas, E.U. Steinhauer, T. V. Rajan, & S.G. Nathenson. (1986). Analysis of somatic cell H-2 variants to define the structural requirements for class I antigen expression.. The Journal of Immunology. 137(3). 897–903. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact